We are currently investing in various businesses which are primarily Environment, Social, and Governance (ESG) focused & developed in India. The businesses not only receive funds from us, but we also help them to incubate. We help startup companies and individual entrepreneurs to develop their businesses through ‘Blue Ashva Capital’ & other Marque fund managers. Our Founder/Managing Trustee Ashok Kumar Goel is unreservedly involved with the development of such businesses & regularly mentors the Founders & provides them with his insights & guidance.
Our contribution to Blue Ashva Capital, which is an investment Fund that is backing sustainable and long-term profitable businesses which are solving real challenges and building lasting value in various sectors. As partners, our funds are directed towards the Blue Ashva Sampada Fund which is invested in the businesses that are focused on De- carbonization and Deep-Tech space with active mentoring and support to the Founders of Investee companies.
To Find Out More, Visit - https://www.blueashvacapital.com
Through Ashok Goel Family Office, we have been supporting various businesses including but not limited to Renovel Innovations, USA, a molecules discovery company.
Renovel Innovations is a company located in the heart of Silicon Valley, California that utilizes a core platform technology to create novel candidate molecules based on natural product chemistry. The company has its own database of over 10,000 natural product molecules, which it uses in combination with the NPCC to generate a pipeline of over 500 patented novel small molecules.
The technology employed by RENOVEL rapidly translates the functional motif of natural products into safe and effective next generation medicines in the shortest possible time frame. Over 100 of these molecules have been synthesized and tested as pre-clinical lead candidates in various animal models for multiple disease conditions
RENOVEL's research is focused on five critical health conditions: diabetes, obesity, inflammation, cancer, and neurological disorders. With two branches located in the United States and India, Renovel's quality and breadth of potential candidate pipeline, platform technology, scientific team, and strategic collaborations are uniquely positioned for the rapid discovery of natural product-based new drugs. The Trust is investing in Renovel’s equity as well as on preference stock.
To Find Out More, Visit - https://www.renovelinnovations.com